Detalhe da pesquisa
1.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36632738
2.
Clinical relevance of an objective flow cytometry approach based on limit of detection and limit of quantification for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial.
Haematologica
; 107(12): 2823-2833, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35295076
3.
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.
Hematol Oncol
; 39(3): 326-335, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33739461
4.
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
Br J Haematol
; 189(5): 853-859, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32064595
5.
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.
Blood
; 138(25): 2727-2730, 2021 12 23.
Artigo
Inglês
| MEDLINE | ID: mdl-34587233
6.
Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia.
Haematologica
; 107(1): 334-337, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34647439
7.
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study.
Haematologica
; 107(6): 1470-1473, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35199505
8.
Outcome of relapsed/refractory acute promyelocytic leukaemia in children, adolescents and young adult patients - a 25-year Italian experience.
Br J Haematol
; 195(2): 278-283, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34145572
9.
Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients.
EJHaem
; 5(2): 353-359, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38633115
10.
X-ray Investigation of CsPbI3:EuCl3 Infiltrated into Gig-Lox TiO2 Spongy Layers for Perovskite Solar Cells Applications.
Nanomaterials (Basel)
; 13(22)2023 Nov 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37999264
11.
Lead Detection in a Gig-Lox TiO2 Sponge by X-ray Reflectivity.
Nanomaterials (Basel)
; 13(8)2023 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37110982
12.
Peripherally inserted central venous catheter for pediatric acute leukemia: A retrospective 11-year single-center experience.
J Vasc Access
; : 11297298231185222, 2023 Jul 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37408515
13.
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol.
Blood Adv
; 6(8): 2510-2516, 2022 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34731884
14.
Childhood acute promyelocytic leukemia in a pediatric cancer referral center in Baghdad, Iraq. Improved results with ATRA extended consolidation.
Leuk Lymphoma
; 63(12): 2940-2947, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35913396
15.
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol.
Cancers (Basel)
; 14(12)2022 Jun 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35740677
16.
TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia.
Front Oncol
; 11: 637186, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33937038
17.
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings.
Leuk Lymphoma
; 64(2): 483-486, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36533589
18.
Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia.
Leuk Lymphoma
; 63(6): 1512-1514, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35133227
19.
CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia.
Leuk Lymphoma
; 63(4): 996-1000, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34806525
20.
[Performance. Regional differences in the National Health Service]. / Performance. Disomogeneità regionali del Servizio Sanitario Nazionale.
Epidemiol Prev
; 35(5-6 Suppl 2): 126-7, 2011.
Artigo
Italiano
| MEDLINE | ID: mdl-22166886